EoinPaulFlanaganMDMB.BCh

Neuroimmunology/Multiple Sclerosis

Professor of Neurology, Department of Neurology, Mayo Clinic

Dr. Flanagan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr Eoin Flanagan is a Professor of Neurology and Consultant in the departments of Neurology and Laboratory Medicine and Pathology at the Mayo Clinic (Rochester, MN). He completed his medical school training at University College Dublin in Ireland in 2005. He did a medical residency in Ireland and then completed neurology residency, fellowships in neuroimmunology and a masters in clinical an translational science at Mayo Clinic (Rochester, MN). He works in the Autoimmune Neurology and Multiple Sclerosis Clinics and the Neuroimmunology Laboratory at the Mayo Clinic. His clinical expertise and research is focused on inflammatory myelopathies and their imaging patterns, Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated disorder, neuromyelitis optica spectrum disorders, autoimmune encephalitis, paraneoplastic neurologic disorders and multiple sclerosis. He is principal investigator on an NIH RO1 grant studying MOG antibody associated disorder.

Mayo School of Graduate Medical EducationM.S., Biomedical Sciences and Clinical and Translational Science, 2012 - 2016
Mayo Clinic College of Medicine and ScienceFellowship, Behavioral neurology, 2014 - 2015
Mayo Clinic College of Medicine and ScienceFellowship, Autoimmune Neurology, 2013 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Neuroimmunology & Multiple Sclerosis, 2012 - 2013
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2009 - 2012
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2008 - 2009
University College of Dublin National Univ SOMClass of 2005

PubMed

118 citations
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.
Elia Sechi, Laura Cacciaguerra, John J Chen, Sara Mariotto, Giulia Fadda
Frontiers in Neurology. 2022-01-01
127 citations
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
Elia Sechi, Marina Buciuc, Sean J. Pittock, John J. Chen, James P. Fryer
JAMA Neurology. 2021-06-01
25 citations
Longitudinal Retinal Changes in MOGAD.
Frederike Cosima Oertel, Elias S Sotirchos, Hanna G Zimmermann, Seyedamirhosein Motamedi, Svenja Specovius
Annals of Neurology. 2022-09-01

Journal Articles

Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated Disorders
Amy Kunchok, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittock, JAMA Neurology
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis
Divyanshu Dubey, John Cheville, Thomas Kryzer, Chadwick Hales, Jorge Kattah, Eoin P Flanagan, Anastasia Zekeridou, Jenny J Linnoila, Andrew Mckeon, Sean J Pittock, JAMA Neurology
Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria
Allen J Aksamit, Karl N Krecke, Giuseppe Lanzino, Alejandro A Rabinstein, J D Bartleson, Melissa M Blessing, Nicholas L Zalewski, Timothy J Kaufmann, Brian G Weinshenk..., JAMA
Unique Gadolinium Enhancement Pattern in Spinal Dural Arteriovenous Fistulas
Timothy J Kaufmann, Nicholas L Zalewski, Waleed Brinjikji, Eoin P Flanagan, Alejandro A Rabinstein, Michael W Ruff, JAMA
Join now to see all

Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAugust 2020
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020